Cargando…
Evaluation of MCT1, MCT4 and CD147 Genes in Peripheral Blood Cells of Breast Cancer Patients and Their Potential Use as Diagnostic and Prognostic Markers
Background: Patients with breast cancer—the deadliest cancer among women—are at constant risk of developing metastasis. Oxidative stress and hypoxia are common feature of tumor cells that can proliferate even in a resultant metabolic acidosis. Despite the low extracellular pH, intracellular pH of tu...
Autores principales: | Luz, Maria Cláudia de B., Perez, Matheus M., Azzalis, Ligia A., Sousa, Luiz Vinícius de A., Adami, Fernando, Fonseca, Fernando L. A., Alves, Beatriz da C. A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5412261/ https://www.ncbi.nlm.nih.gov/pubmed/28333070 http://dx.doi.org/10.3390/ijms18040170 |
Ejemplares similares
-
Expression of TNFR1, VEGFA, CD147 and MCT1 as early biomarkers of diabetes complications and the impact of aging on this profile
por: Raimundo, Joyce Regina Santos, et al.
Publicado: (2023) -
Prognostic Indications of Elevated MCT4 and CD147 across Cancer Types: A Meta-Analysis
por: Bovenzi, Cory D., et al.
Publicado: (2015) -
Inhibition of Hypothalamic MCT4 and MCT1–MCT4 Expressions Affects Food Intake and Alters Orexigenic and Anorexigenic Neuropeptide Expressions
por: Elizondo-Vega, Roberto, et al.
Publicado: (2019) -
MCT4 surpasses the prognostic relevance of the ancillary protein CD147 in clear cell renal cell carcinoma
por: Fisel, Pascale, et al.
Publicado: (2015) -
Monocarboxylate transporter 4 (MCT4) and CD147 overexpression is associated with poor prognosis in prostate cancer
por: Pértega-Gomes, Nelma, et al.
Publicado: (2011)